Overview

Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

Status:
Completed
Trial end date:
2017-11-21
Target enrollment:
Participant gender:
Summary
To compare safety and efficacy of Perrigo's antiviral drug product compared to an FDA approved antiviral drug product in the treatment of cold sores.
Phase:
Phase 3
Details
Lead Sponsor:
Padagis LLC
Perrigo Company
Treatments:
Acyclovir